H7HLAII DNA Influenza Vaccine

N/A

Report date: 2023/10/20 20:06:50

Base Information

Drug NameH7HLAII DNA Influenza Vaccine
Drug Alias NameH7HLAII
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOslo University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesOslo University Hospital
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A